 |
 |
          |
|
Our Investments Viralytics has made a number of investments in healthcare companies, including: Injet Digital Aerosols Limited (formerly known as Vapotronics Inc) to develop the next generation drug inhalation device CBio Ltd to develop chaperonin-10, a potential treatment for a number of autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. |
|
|
|
||||||||
   
|
||||||||||||||
